Last $6.16 USD
Change Today -0.05 / -0.81%
Volume 28.4K
FLML On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christian Trepo

Member of Scientific Advisory Board, Flamel Technologies SA
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Prof. Christian Trepo has been the Head of the Internal Medicine Department and Head of the Hepato-Gastroenterology Department (Hôtel Dieu, Hospices Civils de Lyon). Prof. Trepo has headed extensive research activities, particularly as Head of the Hepatology research team at INSERM Unit 45, Assistant director of the CNRS LP 5440 Epidemiology Centre and Director of INSERM Unit 271, Hepatitis viruses, retroviruses and associated disease. Prof. Trépo has had a wide range ...

Read Full Background

Corporate Headquarters*

33, avenue du Docteur Georges Levy
Vénissieux, Rhône-Alpes 69693

France

Phone: 33 4 72 78 34 34
Fax: 33 4 72 78 34 35

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FLML:US $6.16 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$454.9K
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
$470.0K
Judith Greciet Ph.D., PharmacyChief Executive Officer and Director
BioAlliance Pharma
€269.8K
George W. Hebard III, M.B.AInterim Principal Executive Officer, Interim Chief Operating Officer and Director
Enzon Pharmaceuticals Inc.
$226.4K
Gary R. Maharaj Chief Executive Officer, President and Director
SurModics, Inc.
$475.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLAMEL TECHNOLOGIES-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.